logo
episode-header-image
Oct 2021
29m 31s

Sick Money (Pt 1): Exposing the drug com...

THE TIMES
About this episode

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry.

How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 10,000 times as much for the same drugs? Today: how a company made millions by raising the price on drugs that should have cost pennies.

This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today and get one month free at: thetimes.co.uk/storiesofourtimes.

Guest: Billy Kenber, investigations reporter, The Times.

Host: David Aaronovitch.


Hosted on Acast. See acast.com/privacy for more information.

Up next
Today
Meet the man selling ‘doom’ to Zuckerberg and the Tate brothers - the Long Weekend Story
Ron Hubbard is the biggest builder of underground bunkers, giving security to wealthy buyers who fear the world is coming to an end. And business is boomingThis podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: http:// ... Show More
9m 9s
Yesterday
The prison chief linked to organised crime - the Sunday Story
Bobby Cunningham was 31 when he became Head of Security at Wandsworth Prison, Britain’s most notorious jail, where he was tasked with fighting corruption. The Sunday Times's Whitehall editor Gabriel Pogrund reveals his dealings with organised crime.This podcast was brought to you ... Show More
38m 35s
Aug 23
Inside the Church of England's 'sex cult' - the Saturday Story
Chris Brain, the leader of a Church of England ‘sex cult’ known s the Nine O'Clock Service, has been found guilty of 17 charges of indecent assault, three decades after its collapse. Why did the Church fail to learn lessons from the scandal?This podcast was brought to you thanks ... Show More
33m 39s
Recommended Episodes
Nov 2023
How to Buy DRUGS: The Finances of the Pharmaceutical Industry with Hitha Palepu
On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ... Show More
41m 53s
May 2024
Trillion Dollar Shot, Episode 2: Bank Breakers
As demand for the new class of GLP-1 weight-loss drugs skyrockets, one thing has stood in the way of many people trying to access them: cost. With a price tag around $1,000 a month for U.S. patients and many insurance companies refusing to cover these drugs for weight loss, patie ... Show More
40m 44s
Aug 2023
A Major Overhaul of Prescription Drug Prices
A year ago, Congress overhauled the way drugs for older Americans get paid for, by giving Medicare the power to bargain with drug makers over prices in the biggest change to health care for more than a decade. This week, the Biden administration began its implementation.Sheryl Ga ... Show More
32m 45s
Sep 2023
Money Talks: The price of cheaper medicines
One of the many aims of President Joe Biden’s signature legislation, the Inflation Reduction Act, is to cut the cost of drugs prescribed by Medicare, a government health insurance programme for Americans 65 and over. But the policy could have some side-effects for patients far be ... Show More
44m 53s
Sep 2023
Why One Drug Company Held Back a Better Drug
For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.Rebecca Robbins, who co ... Show More
35m 38s
Jan 2020
The pharmacists fighting high drug prices
If you had a rare disease and the only drug that could help you suddenly shot up in price how would you feel? What if your health service or insurer decided it was too expensive and they wouldn’t fund it any more? This is the problem facing some patients in the Netherlands.In ord ... Show More
23m 40s
Apr 2024
Money Talks: Why weight-loss drugs will reshape the world
More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that ... Show More
36m 59s
Sep 2023
Money Talks: The price of cheaper medicines
One of the many aims of President Joe Biden’s signature legislation, the Inflation Reduction Act, is to cut the cost of drugs prescribed by Medicare, a government health insurance programme for Americans 65 and over. But the policy could have some side-effects for patients far be ... Show More
44m 53s